{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:13:35Z","timestamp":1778426015161,"version":"3.51.4"},"reference-count":95,"publisher":"e-Century Publishing Corporation","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/kskh3925","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T07:04:45Z","timestamp":1756451085000},"page":"3617-3631","source":"Crossref","is-referenced-by-count":2,"title":["Targeting ferroptosis and immune surveillance in gastric cancer with traditional Chinese medicine monomers: a dual-targeted strategy for epithelial-mesenchymal transition and angiogenesis"],"prefix":"10.62347","volume":"15","author":[{"given":"Yijia","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000334677","article-title":"Recent advances in diagnosis and treatment for malignancies of the gastrointestinal tract","volume":"85","author":"Watanabe","year":"2012","unstructured":"Watanabe M, Baba H, Ishioka C, Nishimura Y and Muto M. Recent advances in diagnosis and treatment for malignancies of the gastrointestinal tract. Digestion 2012; 85: 95-98.","journal-title":"Digestion"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.3748\/wjg.v20.i18.5403","article-title":"Role of epithelial-mesenchymal transition in gastric cancer initiation and progression","volume":"20","author":"Peng","year":"2014","unstructured":"Peng Z, Wang CX, Fang EH, Wang GB and Tong Q. Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World J Gastroenterol 2014; 20: 5403-5410.","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","unstructured":"Lugano R, Ramachandran M and Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci 2020; 77: 1745-1770.","journal-title":"Cell Mol Life Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41419-022-05384-6","article-title":"Ferroptosis: a double-edged sword mediating immune tolerance of cancer","volume":"13","author":"Dang","year":"2022","unstructured":"Dang Q, Sun Z, Wang Y, Wang L, Liu Z and Han X. Ferroptosis: a double-edged sword mediating immune tolerance of cancer. Cell Death Dis 2022; 13: 925.","journal-title":"Cell Death Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1021\/acsnano.9b00892","article-title":"Engineering magnetosomes for ferroptosis\/immunomodulation synergism in cancer","volume":"13","author":"Zhang","year":"2019","unstructured":"Zhang F, Li F, Lu GH, Nie W, Zhang L, Lv Y, Bao W, Gao X, Wei W, Pu K and Xie HY. Engineering magnetosomes for ferroptosis\/immunomodulation synergism in cancer. ACS Nano 2019; 13: 5662-5673.","journal-title":"ACS Nano"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","article-title":"Ferroptosis and the tumor microenvironment","volume":"43","author":"Cui","year":"2024","unstructured":"Cui K, Wang K and Huang Z. Ferroptosis and the tumor microenvironment. J Exp Clin Cancer Res 2024; 43: 315.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Liu C, Liu Z, Dong Z, Liu S, Kan H and Zhang S. Multifaceted interplays between the essential players and lipid peroxidation in ferroptosis. J Genet Genomics 2025; [Epub ahead of print].","DOI":"10.1016\/j.jgg.2025.01.009"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41581-023-00689-x","article-title":"Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney","volume":"19","author":"Bay&#x131","year":"2023","unstructured":"Bayır H, Dixon SJ, Tyurina YY, Kellum JA and Kagan VE. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat Rev Nephrol 2023; 19: 315-336.","journal-title":"Nat Rev Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/md23060258","article-title":"Targeting ferroptosis in tumors: novel marine-derived compounds as regulators of lipid peroxidation and GPX4 signaling","volume":"23","author":"Wu","year":"2025","unstructured":"Wu Y, Chen X, Chen Z and Ma Y. Targeting ferroptosis in tumors: novel marine-derived compounds as regulators of lipid peroxidation and GPX4 signaling. Mar Drugs 2025; 23: 258.","journal-title":"Mar Drugs"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.3389\/fimmu.2018.02040","article-title":"NKG2D ligands-critical targets for cancer immune escape and therapy","volume":"9","author":"Schmiedel","year":"2018","unstructured":"Schmiedel D and Mandelboim O. NKG2D ligands-critical targets for cancer immune escape and therapy. Front Immunol 2018; 9: 2040.","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41577-020-0390-6","article-title":"A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion","volume":"21","author":"Dersh","year":"2021","unstructured":"Dersh D, Holly J and Yewdell JW. A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion. Nat Rev Immunol 2021; 21: 116-128.","journal-title":"Nat Rev Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40659-025-00597-3","article-title":"Recent advances in the mechanisms of PD-L1 expression in gastric cancer: a review","volume":"58","author":"Chen","year":"2025","unstructured":"Chen P, Chen Z, Sui W and Han W. Recent advances in the mechanisms of PD-L1 expression in gastric cancer: a review. Biol Res 2025; 58: 16.","journal-title":"Biol Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses","volume":"162","author":"PC","year":"2015","unstructured":"Ho PC, Bihuniak JD, Macintyre AN, Staron M, Liu X, Amezquita R, Tsui YC, Cui G, Micevic G, Perales JC, Kleinstein SH, Abel ED, Insogna KL, Feske S, Locasale JW, Bosenberg MW, Rathmell JC and Kaech SM. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 2015; 162: 1217-1228.","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3390\/cells9040992","article-title":"Hypoxia-driven immune escape in the tumor microenvironment","volume":"9","author":"Vito","year":"2020","unstructured":"Vito A, El-Sayes N and Mossman K. Hypoxia-driven immune escape in the tumor microenvironment. Cells 2020; 9: 992.","journal-title":"Cells"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","unstructured":"Wu Q, You L, Nepovimova E, Heger Z, Wu W, Kuca K and Adam V. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. J Hematol Oncol 2022; 15: 77.","journal-title":"J Hematol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12967-025-06287-8","article-title":"1 is a ferroptosis-related target identified by a novel mitochondria-related lncRNA signature that is involved in the tumor immune microenvironment in gastric cancer","volume":"23","author":"Yu","year":"2025","unstructured":"Yu S, Liang J, Liu L, Chen M, Chen C and Zhou D. AC129507.1 is a ferroptosis-related target identified by a novel mitochondria-related lncRNA signature that is involved in the tumor immune microenvironment in gastric cancer. J Transl Med 2025; 23: 290.","journal-title":"J Transl Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-023-02925-5","article-title":"Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment","volume":"43","author":"Hua","year":"2024","unstructured":"Hua Y, Yang S, Zhang Y, Li J, Wang M, Yeerkenbieke P, Liao Q and Liu Q. Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment. J Exp Clin Cancer Res 2024; 43: 19.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"117298","DOI":"10.1016\/j.biopha.2024.117298","article-title":"Firing up “cold” tumors: ferroptosis causes immune activation by improving T cell infiltration","volume":"179","author":"Li","year":"2024","unstructured":"Li X, Li Y, Tuerxun H, Zhao Y, Liu X and Zhao Y. Firing up “cold” tumors: ferroptosis causes immune activation by improving T cell infiltration. Biomed Pharmacother 2024; 179: 117298.","journal-title":"Biomed Pharmacother"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1111\/febs.16093","article-title":"Inflammatory cell death induced by cytotoxic lymphocytes: a dangerous but necessary liaison","volume":"289","author":"de Miguel","year":"2022","unstructured":"de Miguel D, Ramirez-Labrada A, Uranga I, Hidalgo S, Santiago L, Galvez EM, Arias M and Pardo J. Inflammatory cell death induced by cytotoxic lymphocytes: a dangerous but necessary liaison. FEBS J 2022; 289: 4398-4415.","journal-title":"FEBS J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial-mesenchymal transition","volume":"21","author":"Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, Garcia de Herreros A, Goodall GJ, Hadjantonakis AK, Huang RYJ, Kalcheim C, Kalluri R, Kang Y, Khew-Goodall Y, Levine H, Liu J, Longmore GD, Mani SA, Massague J, Mayor R, McClay D, Mostov KE, Newgreen DF, Nieto MA, Puisieux A, Runyan R, Savagner P, Stanger B, Stemmler MP, Takahashi Y, Takeichi M, Theveneau E, Thiery JP, Thompson EW, Weinberg RA, Williams ED, Xing J, Zhou BP and Sheng G; EMT International Association (TEMTIA). Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2020; 21: 341-352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-025-02338-2","article-title":"Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025","volume":"24","author":"Allgayer","year":"2025","unstructured":"Allgayer H, Mahapatra S, Mishra B, Swain B, Saha S, Khanra S, Kumari K, Panda VK, Malhotra D, Patil NS, Leupold JH and Kundu GC. Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025. Mol Cancer 2025; 24: 167.","journal-title":"Mol Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"114395","DOI":"10.1016\/j.biopha.2023.114395","article-title":"Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: metastasis, therapy response, and revisiting molecular pathways","volume":"160","author":"Sabouni","year":"2023","unstructured":"Sabouni E, Nejad MM, Mojtabavi S, Khoshduz S, Mojtabavi M, Nadafzadeh N, Nikpanjeh N, Mirzaei S, Hashemi M, Aref AR, Khorrami R, Nabavi N, Ertas YN, Salimimoghadam S, Zandieh MA, Rahmanian P, Taheriazam A and Hushmandi K. Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: metastasis, therapy response, and revisiting molecular pathways. Biomed Pharmacother 2023; 160: 114395.","journal-title":"Biomed Pharmacother"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","article-title":"TGF-beta-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","unstructured":"Xu J, Lamouille S and Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19: 156-172.","journal-title":"Cell Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1096\/fj.201801728R","article-title":"SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells","volume":"33","author":"Xin","year":"2019","unstructured":"Xin L, Zhao R, Lei J, Song J, Yu L, Gao R, Ha C, Ren Y, Liu X, Liu Y, Yao Z and Yang J. SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells. FASEB J 2019; 33: 3795-3806.","journal-title":"FASEB J"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.2174\/1389450119666180207092234","article-title":"Radiationinduced pulmonary epithelial-mesenchymal transition: a review on targeting molecular pathways and mediators","volume":"19","author":"Nagaraja","year":"2018","unstructured":"Nagaraja SS and Nagarajan D. Radiationinduced pulmonary epithelial-mesenchymal transition: a review on targeting molecular pathways and mediators. Curr Drug Targets 2018; 19: 1191-1204.","journal-title":"Curr Drug Targets"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Sravani ANKV and Thomas J. Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers. Heliyon 2025; 11: e41964.","DOI":"10.1016\/j.heliyon.2025.e41964"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"136560","DOI":"10.1016\/j.chemosphere.2022.136560","article-title":"Contribution of common plastic-related endocrine disruptors to epithelial-mesenchymal transition (EMT) and tumor progression","volume":"309","author":"Pesonen","year":"2022","unstructured":"Pesonen M and Vahakangas K. Contribution of common plastic-related endocrine disruptors to epithelial-mesenchymal transition (EMT) and tumor progression. Chemosphere 2022; 309: 136560.","journal-title":"Chemosphere"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-023-02593-5","article-title":"Correction: resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN\/Akt signaling pathway in gastric cancer","volume":"42","author":"Xu","year":"2023","unstructured":"Xu J, Liu D, Niu H, Zhu G, Xu Y, Ye D, Li J and Zhang Q. Correction: resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN\/Akt signaling pathway in gastric cancer. J Exp Clin Cancer Res 2023; 42: 23.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/biology10020146","article-title":"The role and expression of angiogenesis-related miRNAs in gastric cancer","volume":"10","author":"Giuppi","year":"2021","unstructured":"Giuppi M, La Salvia A, Evangelista J and Ghidini M. The role and expression of angiogenesis-related miRNAs in gastric cancer. Biology (Basel) 2021; 10: 146.","journal-title":"Biology (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3390\/cancers14112711","article-title":"The HIF-1α as a potent inducer of the hallmarks in gastric cancer","volume":"14","author":"Ucaryilmaz Metin","year":"2022","unstructured":"Ucaryilmaz Metin C and Ozcan G. The HIF-1α as a potent inducer of the hallmarks in gastric cancer. Cancers (Basel) 2022; 14: 2711.","journal-title":"Cancers (Basel)"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"468725","DOI":"10.1155\/2010\/468725","article-title":"Angiogenesis and lymphangiogenesis of gastric cancer","volume":"2010","author":"Kitadai","year":"2010","unstructured":"Kitadai Y. Angiogenesis and lymphangiogenesis of gastric cancer. J Oncol 2010; 2010: 468725.","journal-title":"J Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"118867","DOI":"10.1016\/j.jep.2024.118867","article-title":"The molecular mechanisms of Caulophyllum robustum Maxim extract inhibition by regulating FAK\/PI3K signaling pathway in gastric cancer HGC-27 cells","volume":"337","author":"Cui","year":"2025","unstructured":"Cui M, Yao G, Zhang Y, Wen M, Zhang S, Jin J, Lin Z, Ren X, An R and Piao Y. The molecular mechanisms of Caulophyllum robustum Maxim extract inhibition by regulating FAK\/PI3K signaling pathway in gastric cancer HGC-27 cells. J Ethnopharmacol 2025; 337: 118867.","journal-title":"J Ethnopharmacol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12032-024-02455-w","article-title":"Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay","volume":"41","author":"Elimam","year":"2024","unstructured":"Elimam H, Abdel Mageed SS, Hatawsh A, Moussa R, Radwan AF, Elfar N, Alhamshry NAA, Abd-Elmawla MA, Mohammed OA, Zaki MB and Doghish AS. Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay. Med Oncol 2024; 41: 218.","journal-title":"Med Oncol"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Hei B, Liu RE and Li M. Ursolic acid inhibits glioblastoma through suppressing TGFβ-mediated epithelial-mesenchymal transition (EMT) and angiogenesis. Heliyon 2024; 10: e27722.","DOI":"10.1016\/j.heliyon.2024.e27722"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/cancers6010240","article-title":"Gelatinase B\/MMP-9 in tumour pathogenesis and progression","volume":"6","author":"Farina","year":"2014","unstructured":"Farina AR and Mackay AR. Gelatinase B\/MMP-9 in tumour pathogenesis and progression. Cancers (Basel) 2014; 6: 240-296.","journal-title":"Cancers (Basel)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s12253-009-9158-9","article-title":"Prognostic value of tumor-related molecular expression in gastric carcinoma","volume":"15","author":"Zhao","year":"2009","unstructured":"Zhao ZS, Wang YY, Ye ZY and Tao HQ. Prognostic value of tumor-related molecular expression in gastric carcinoma. Pathol Oncol Res 2009; 15: 589-596.","journal-title":"Pathol Oncol Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"115672","DOI":"10.1016\/j.envres.2023.115672","article-title":"New insight in urological cancer therapy: from epithelial-mesenchymal transition (EMT) to application of nano-biomaterials","volume":"229","author":"He","year":"2023","unstructured":"He P, Dai Q and Wu X. New insight in urological cancer therapy: from epithelial-mesenchymal transition (EMT) to application of nano-biomaterials. Environ Res 2023; 229: 115672.","journal-title":"Environ Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.3748\/wjg.v12.i47.7598","article-title":"Microvessel density is a prognostic marker of human gastric cancer","volume":"12","author":"Zhao","year":"2006","unstructured":"Zhao HC, Qin R, Chen XX, Sheng X, Wu JF, Wang DB and Chen GH. Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol 2006; 12: 7598-7603.","journal-title":"World J Gastroenterol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"905520","DOI":"10.3389\/fonc.2022.905520","article-title":"Therapeutic targeting of VEGF and\/or TGF-β to enhance anti-PD-(L)1 therapy: the evidence from clinical trials","volume":"12","author":"Li","year":"2022","unstructured":"Li L, Wen Q and Ding R. Therapeutic targeting of VEGF and\/or TGF-β to enhance anti-PD-(L)1 therapy: the evidence from clinical trials. Front Oncol 2022; 12: 905520.","journal-title":"Front Oncol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/molecules22050744","article-title":"Quercetin from polygonum capitatum protects against gastric inflammation and apoptosis associated with helicobacter pylori infection by affecting the levels of p38MAPK, BCL-2 and BAX","volume":"22","author":"Zhang","year":"2017","unstructured":"Zhang S, Huang J, Xie X, He Y, Mo F and Luo Z. Quercetin from polygonum capitatum protects against gastric inflammation and apoptosis associated with helicobacter pylori infection by affecting the levels of p38MAPK, BCL-2 and BAX. Molecules 2017; 22: 744.","journal-title":"Molecules"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.freeradbiomed.2024.01.002","article-title":"Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2\/p-DRP1 and NRF2\/GPX4 Axes","volume":"213","author":"Ding","year":"2024","unstructured":"Ding L, Dang S, Sun M, Zhou D, Sun Y, Li E, Peng S, Li J and Li G. Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2\/p-DRP1 and NRF2\/GPX4 Axes. Free Radic Biol Med 2024; 213: 150-163.","journal-title":"Free Radic Biol Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1002\/ptr.7297","article-title":"Quercetin inhibiting the PD-1\/PD-L1 interaction for immune-enhancing cancer chemopreventive agent","volume":"35","author":"Jing","year":"2021","unstructured":"Jing L, Lin J, Yang Y, Tao L, Li Y, Liu Z, Zhao Q and Diao A. Quercetin inhibiting the PD-1\/PD-L1 interaction for immune-enhancing cancer chemopreventive agent. Phytother Res 2021; 35: 6441-6451.","journal-title":"Phytother Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/pgpm.s511324","article-title":"Quercetin inhibits gastric cancer progression via FAM198B\/MAPK pathway modulation","volume":"18","author":"Deng","year":"2025","unstructured":"Deng H, Xiao Q, Xu X, Zhang L and Zhang Y. Quercetin inhibits gastric cancer progression via FAM198B\/MAPK pathway modulation. Pharmgenomics Pers Med 2025; 18: 115-141.","journal-title":"Pharmgenomics Pers Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1563229","DOI":"10.3389\/fphar.2025.1563229","article-title":"A review on anti-cancer properties of quercetin in gastric cancer","volume":"16","author":"Xie","year":"2025","unstructured":"Xie X and Wei Y. A review on anti-cancer properties of quercetin in gastric cancer. Front Pharmacol 2025; 16: 1563229.","journal-title":"Front Pharmacol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"114509","DOI":"10.1016\/j.ejpb.2024.114509","article-title":"Cancer cell membrane-camouflaged curcumin nanoparticles trigger ferroptosis for accurate gastric cancer therapy","volume":"204","author":"Fan","year":"2024","unstructured":"Fan Y, Zhang X, Zhao J, Chen S and Liang J. Cancer cell membrane-camouflaged curcumin nanoparticles trigger ferroptosis for accurate gastric cancer therapy. Eur J Pharm Biopharm 2024; 204: 114509.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"675923","DOI":"10.3389\/fonc.2021.675923","article-title":"Curcumin as an adjuvant to cancer immunotherapy","volume":"11","author":"Paul","year":"2021","unstructured":"Paul S and Sa G. Curcumin as an adjuvant to cancer immunotherapy. Front Oncol 2021; 11: 675923.","journal-title":"Front Oncol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.3892\/ol.2020.11437","article-title":"The roles of curcumin in regulating the tumor immunosuppressive microenvironment","volume":"19","author":"Wang","year":"2020","unstructured":"Wang Y, Lu J, Jiang B and Guo J. The roles of curcumin in regulating the tumor immunosuppressive microenvironment. Oncol Lett 2020; 19: 3059-3070.","journal-title":"Oncol Lett"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"934534","DOI":"10.3389\/fphar.2022.934534","article-title":"Curcuminoids as modulators of EMT in invasive cancers: a review of molecular targets with the contribution of malignant mesothelioma studies","volume":"13","author":"Pouliquen","year":"2022","unstructured":"Pouliquen DL, Boissard A, Henry C, Coqueret O and Guette C. Curcuminoids as modulators of EMT in invasive cancers: a review of molecular targets with the contribution of malignant mesothelioma studies. Front Pharmacol 2022; 13: 934534.","journal-title":"Front Pharmacol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13008-015-0012-z","article-title":"Curcumin and tumor immune-editing: resurrecting the immune system","volume":"10","author":"Bose","year":"2015","unstructured":"Bose S, Panda AK, Mukherjee S and Sa G. Curcumin and tumor immune-editing: resurrecting the immune system. Cell Div 2015; 10: 6.","journal-title":"Cell Div"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1290120","DOI":"10.3389\/fphar.2024.1290120","article-title":"Ferroptosis: a new mechanism of traditional Chinese medicine for cancer treatment","volume":"15","author":"Zhu","year":"2024","unstructured":"Zhu J, Shen P, Xu Y, Zhang X, Chen Q, Gu K, Ji S, Yang B and Zhao Y. Ferroptosis: a new mechanism of traditional Chinese medicine for cancer treatment. Front Pharmacol 2024; 15: 1290120.","journal-title":"Front Pharmacol"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Lu X, Li Y, Yang W, Tao M, Dai Y, Xu J and Xu Q. Inhibition of NF-κB is required for oleanolic acid to downregulate PD-L1 by promoting DNA demethylation in gastric cancer cells. J Biochem Mol Toxicol 2021; 35: e22621.","DOI":"10.1002\/jbt.22621"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"155656","DOI":"10.1016\/j.cyto.2021.155656","article-title":"Oleanolic acid regulates the Treg\/Th17 imbalance in gastric cancer by targeting IL-6 with miR-98-5p","volume":"148","author":"QF","year":"2021","unstructured":"Xu QF, Peng HP, Lu XR, Hu Y, Xu ZH and Xu JK. Oleanolic acid regulates the Treg\/Th17 imbalance in gastric cancer by targeting IL-6 with miR-98-5p. Cytokine 2021; 148: 155656.","journal-title":"Cytokine"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"7740","DOI":"10.3390\/ijms23147740","article-title":"Recent advances regarding the molecular mechanisms of triterpenic acids: a review (part I)","volume":"23","author":"Mioc","year":"2022","unstructured":"Mioc M, Milan A, Maliţa D, Mioc A, Prodea A, Racoviceanu R, Ghiulai R, Cristea A, Căruntu F and Șoica C. Recent advances regarding the molecular mechanisms of triterpenic acids: a review (part I). Int J Mol Sci 2022; 23: 7740.","journal-title":"Int J Mol Sci"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/ijms18030643","article-title":"Oleanolic acid alters multiple cell signaling pathways: implication in cancer prevention and therapy","volume":"18","author":"&#x17D","year":"2017","unstructured":"Žiberna L, Šamec D, Mocan A, Nabavi SF, Bishayee A, Farooqi AA, Sureda A and Nabavi SM. Oleanolic acid alters multiple cell signaling pathways: implication in cancer prevention and therapy. Int J Mol Sci 2017; 18: 643.","journal-title":"Int J Mol Sci"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.3390\/ijms24076588","article-title":"Berberine induces combined cell death in gastrointestinal cell lines","volume":"24","author":"Mori","year":"2023","unstructured":"Mori S, Fujiwara-Tani R, Gyoten M, Nukaga S, Sasaki R, Ikemoto A, Ogata R, Kishi S, Fujii K and Kuniyasu H. Berberine induces combined cell death in gastrointestinal cell lines. Int J Mol Sci 2023; 24: 6588.","journal-title":"Int J Mol Sci"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.3390\/molecules27185889","article-title":"Berberine: an important emphasis on its anticancer effects through modulation of various cell signaling pathways","volume":"27","author":"SA","year":"2022","unstructured":"Almatroodi SA, Alsahli MA and Rahmani AH. Berberine: an important emphasis on its anticancer effects through modulation of various cell signaling pathways. Molecules 2022; 27: 5889.","journal-title":"Molecules"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"153904","DOI":"10.1016\/j.phymed.2021.153904","article-title":"Berberine mediates tumor cell death by skewing tumor-associated immunosuppressive macrophages to inflammatory macrophages","volume":"99","author":"Shah","year":"2022","unstructured":"Shah D, Challagundla N, Dave V, Patidar A, Saha B, Nivsarkar M, Trivedi VB and Agrawal-Rajput R. Berberine mediates tumor cell death by skewing tumor-associated immunosuppressive macrophages to inflammatory macrophages. Phytomedicine 2022; 99: 153904.","journal-title":"Phytomedicine"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"2337818","DOI":"10.1155\/2021\/2337818","article-title":"Berberine suppresses EMT in liver and gastric carcinoma cells through combination with TGFβR regulating TGF-β\/Smad pathway","volume":"2021","author":"Du","year":"2021","unstructured":"Du H, Gu J, Peng Q, Wang X, Liu L, Shu X, He Q and Tan Y. Berberine suppresses EMT in liver and gastric carcinoma cells through combination with TGFβR regulating TGF-β\/Smad pathway. Oxid Med Cell Longev 2021; 2021: 2337818.","journal-title":"Oxid Med Cell Longev"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1186\/s12885-019-5791-1","article-title":"Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis","volume":"19","author":"Xu","year":"2019","unstructured":"Xu J, Long Y, Ni L, Yuan X, Yu N, Wu R, Tao J and Zhang Y. Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. BMC Cancer 2019; 19: 589.","journal-title":"BMC Cancer"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1473939","DOI":"10.3389\/fphar.2024.1473939","article-title":"Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics","volume":"15","author":"Peng","year":"2024","unstructured":"Peng L, Hu XZ, Liu ZQ, Liu WK, Huang Q and Wen Y. Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics. Front Pharmacol 2024; 15: 1473939.","journal-title":"Front Pharmacol"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Zhao X, Lu S, Yan M, Zhu ZG, Dong F and Yan C. Resveratrol targets mitochondrial USP36-SOD2 to induce autophagy-ferroptosis and inhibit gastric cancer progression. Gastric Cancer 2025; [Epub ahead of print].","DOI":"10.1007\/s10120-025-01645-3"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1086368","DOI":"10.3389\/fgene.2023.1086368","article-title":"Development of alternative herbals remedy for gastric cancer based on transcriptomic analysis of immune infiltration and ferroptosis","volume":"14","author":"Li","year":"2023","unstructured":"Li M, Tao J, Qian R, Jiang F, Song Y, Zeng Z and Cai C. Development of alternative herbals remedy for gastric cancer based on transcriptomic analysis of immune infiltration and ferroptosis. Front Genet 2023; 14: 1086368.","journal-title":"Front Genet"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1031438","DOI":"10.3389\/fphar.2022.1031438","article-title":"Resveratrol activates CD8(+) T cells through IL-18 bystander activation in lung adenocarcinoma","volume":"13","author":"Zhang","year":"2022","unstructured":"Zhang W, Zhang R, Chang Z and Wang X. Resveratrol activates CD8(+) T cells through IL-18 bystander activation in lung adenocarcinoma. Front Pharmacol 2022; 13: 1031438.","journal-title":"Front Pharmacol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.3892\/ol.2015.2988","article-title":"Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis","volume":"9","author":"Gao","year":"2015","unstructured":"Gao Q, Yuan Y, Gan HZ and Peng Q. Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis. Oncol Lett 2015; 9: 2381-2387.","journal-title":"Oncol Lett"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/nu8110628","article-title":"Unraveling the anticancer effect of curcumin and resveratrol","volume":"8","author":"Pavan","year":"2016","unstructured":"Pavan AR, Silva GD, Jornada DH, Chiba DE, Fernandes GF, Man Chin C and Dos Santos JL. Unraveling the anticancer effect of curcumin and resveratrol. Nutrients 2016; 8: 628.","journal-title":"Nutrients"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"114986","DOI":"10.1016\/j.biopha.2023.114986","article-title":"Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis","volume":"164","author":"Yuan","year":"2023","unstructured":"Yuan J, Khan SU, Yan J, Lu J, Yang C and Tong Q. Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis. Biomed Pharmacother 2023; 164: 114986.","journal-title":"Biomed Pharmacother"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"10745","DOI":"10.1038\/s41598-024-60920-y","article-title":"Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis","volume":"14","author":"Shao","year":"2024","unstructured":"Shao L, Zhu L, Su R, Yang C, Gao X, Xu Y, Wang H, Guo C and Li H. Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis. Sci Rep 2024; 14: 10745.","journal-title":"Sci Rep"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"494","DOI":"10.7150\/jca.89986","article-title":"Baicalin induces gastric cancer cell pyroptosis through the NF-κB-NLRP3 signaling axis","volume":"15","author":"Liu","year":"2024","unstructured":"Liu J, Qi X, Gu P, Wang L, Song S and Shu P. Baicalin induces gastric cancer cell pyroptosis through the NF-κB-NLRP3 signaling axis. J Cancer 2024; 15: 494-507.","journal-title":"J Cancer"},{"key":"ref69","unstructured":"Ye J, Qiao D, Zhang Y, Piao Y and Jin J. Baicalein blocked gastric cancer cell proliferation and invasion through modulated platelet type 12-lipoxygenase. Iran J Basic Med Sci 2024; 27: 1574-1582."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"154046","DOI":"10.1016\/j.phymed.2022.154046","article-title":"The molecular mechanism of baicalein repressing progression of gastric cancer mediating miR-7\/FAK\/AKT signaling pathway","volume":"100","author":"Qiao","year":"2022","unstructured":"Qiao D, Xing J, Duan Y, Wang S, Yao G, Zhang S, Jin J, Lin Z, Chen L and Piao Y. The molecular mechanism of baicalein repressing progression of gastric cancer mediating miR-7\/FAK\/AKT signaling pathway. Phytomedicine 2022; 100: 154046.","journal-title":"Phytomedicine"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1579609","DOI":"10.3389\/fphar.2025.1579609","article-title":"Recent advancement in the anticancer efficacy of the natural flavonoid scutellarin: a comprehensive review","volume":"16","author":"Elsori","year":"2025","unstructured":"Elsori D, Pandey P, Verma M, Vadia N, Roopashree R, Vyas M, Lakshmi L, Maharana L, Nathiya D, Saeed M, Obaidur Rab S and Khan F. Recent advancement in the anticancer efficacy of the natural flavonoid scutellarin: a comprehensive review. Front Pharmacol 2025; 16: 1579609.","journal-title":"Front Pharmacol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/tox.23388","article-title":"Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis","volume":"37","author":"Ni","year":"2022","unstructured":"Ni H, Ruan G, Sun C, Yang X, Miao Z, Li J, Chen Y, Qin H, Liu Y, Zheng L, Xing Y, Xi T and Li X. Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis. Environ Toxicol 2022; 37: 192-200.","journal-title":"Environ Toxicol"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Guan Z, Chen J, Li X and Dong N. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation. Biosci Rep 2020; 40: BSR20201807.","DOI":"10.1042\/BSR20201807"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"870848","DOI":"10.3389\/fphar.2022.870848","article-title":"Sodium tanshinone IIA sulfonate as a potent IDO1\/TDO2 dual inhibitor enhances anti-PD1 therapy for colorectal cancer in mice","volume":"13","author":"Zhang","year":"2022","unstructured":"Zhang R, Wang Y, Liu D, Luo Q, Du P, Zhang H and Wu W. Sodium tanshinone IIA sulfonate as a potent IDO1\/TDO2 dual inhibitor enhances anti-PD1 therapy for colorectal cancer in mice. Front Pharmacol 2022; 13: 870848.","journal-title":"Front Pharmacol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3892\/or.2017.5408","article-title":"Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1","volume":"37","author":"Yu","year":"2017","unstructured":"Yu J, Wang X, Li Y and Tang B. Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1. Oncol Rep 2017; 37: 1394-1400.","journal-title":"Oncol Rep"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1282203","DOI":"10.3389\/fphar.2023.1282203","article-title":"The mechanisms of tanshinone in the treatment of tumors","volume":"14","author":"Zhang","year":"2023","unstructured":"Zhang P, Liu W and Wang Y. The mechanisms of tanshinone in the treatment of tumors. Front Pharmacol 2023; 14: 1282203.","journal-title":"Front Pharmacol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1568391","DOI":"10.3389\/fonc.2025.1568391","article-title":"Food-derived compounds targeting ferroptosis for cancer therapy: from effects to mechanisms","volume":"15","author":"JW","year":"2025","unstructured":"Zhao JW, Zhao WY and Yu Z. Food-derived compounds targeting ferroptosis for cancer therapy: from effects to mechanisms. Front Oncol 2025; 15: 1568391.","journal-title":"Front Oncol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"156078","DOI":"10.1016\/j.prp.2025.156078","article-title":"Ginsenosides and gastrointestinal cancers: a novel therapeutic strategy in cancer therapy","volume":"272","author":"Karimi","year":"2025","unstructured":"Karimi M, Barjasteh AH, Shariatzadeh M, Taha SR, Fazlollahpour-Naghibi A, Rezaei P, Aghaei Lasboo M, Ghanbari Saray M and Pourhanifeh MH. Ginsenosides and gastrointestinal cancers: a novel therapeutic strategy in cancer therapy. Pathol Res Pract 2025; 272: 156078.","journal-title":"Pathol Res Pract"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Lu Z, Fu Y, Fu Q, Chang Y, Zhang M and Jin T. Ginsenoside RG3 synergizes with STING agonist to reverse cisplatin resistance in gastric cancer. Food Sci Nutr 2025; 13: e4744.","DOI":"10.1002\/fsn3.4744"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"117049","DOI":"10.1016\/j.biopha.2024.117049","article-title":"Ginsenosides in cancer: proliferation, metastasis, and drug resistance","volume":"177","author":"Yang","year":"2024","unstructured":"Yang Y, Nan Y, Du Y, Liu W, Ning N, Chen G, Gu Q and Yuan L. Ginsenosides in cancer: proliferation, metastasis, and drug resistance. Biomed Pharmacother 2024; 177: 117049.","journal-title":"Biomed Pharmacother"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.4251\/wjgo.v16.i9.3798","article-title":"Matching traditional Chinese medicine and western medicine-based research: advanced nutraceutical development for proactive gastric cancer prevention","volume":"16","author":"Micucci","year":"2024","unstructured":"Micucci M, Xiang BZ, Ting CM, Kwan HY, Mari M, Retini M, Burattini S, Osman R, Okeke UJ, Abdullah FO, Gianfanti F and Battistelli M. Matching traditional Chinese medicine and western medicine-based research: advanced nutraceutical development for proactive gastric cancer prevention. World J Gastrointest Oncol 2024; 16: 3798-3819.","journal-title":"World J Gastrointest Oncol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"113756","DOI":"10.1016\/j.biopha.2022.113756","article-title":"Ginsenosides in cancer: a focus on the regulation of cell metabolism","volume":"156","author":"Yao","year":"2022","unstructured":"Yao W and Guan Y. Ginsenosides in cancer: a focus on the regulation of cell metabolism. Biomed Pharmacother 2022; 156: 113756.","journal-title":"Biomed Pharmacother"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR and Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 2021; 22: 266-282.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, Galeas J, Dhruv HD, Berens ME, Schreiber SL, McCormick F and McManus MT. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 2017; 551: 247-250.","journal-title":"Nature"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","unstructured":"Chen DS and Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature 2017; 541: 321-330.","journal-title":"Nature"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2019.10.013","article-title":"Communication between EMT and PD-L1 signaling: new insights into tumor immune evasion","volume":"468","author":"Jiang","year":"2020","unstructured":"Jiang Y and Zhan H. Communication between EMT and PD-L1 signaling: new insights into tumor immune evasion. Cancer Lett 2020; 468: 72-81.","journal-title":"Cancer Lett"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41419-019-2131-y","article-title":"Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer","volume":"10","author":"Li","year":"2019","unstructured":"Li W, Zhang X, Wu F, Zhou Y, Bao Z, Li H, Zheng P and Zhao S. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer. Cell Death Dis 2019; 10: 918.","journal-title":"Cell Death Dis"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Schito L. Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment. Am J Physiol Regul Integr Comp Physiol 2018; 315: R1072-R1084.","DOI":"10.1152\/ajpregu.00209.2018"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1158\/1078-0432.CCR-18-1543","article-title":"The intersection between tumor angiogenesis and immune suppression","volume":"25","author":"Rahma","year":"2019","unstructured":"Rahma OE and Hodi FS. The intersection between tumor angiogenesis and immune suppression. Clin Cancer Res 2019; 25: 5449-5457.","journal-title":"Clin Cancer Res"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","article-title":"The role of tumor-associated macrophages in tumor immune evasion","volume":"150","author":"Huang","year":"2024","unstructured":"Huang R, Kang T and Chen S. The role of tumor-associated macrophages in tumor immune evasion. J Cancer Res Clin Oncol 2024; 150: 238.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/cells12071050","article-title":"Ferroptosis regulated by hypoxia in cells","volume":"12","author":"Zheng","year":"2023","unstructured":"Zheng X, Liang Y and Zhang C. Ferroptosis regulated by hypoxia in cells. Cells 2023; 12: 1050.","journal-title":"Cells"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Lu X, Li D, Lin Z, Gao T, Gong Z, Zhang Y, Wang H, Xia X, Lu F, Song J, Xu G, Jiang J, Ma X and Zou F. HIF-1α-induced expression of the m6A reader YTHDF1 inhibits the ferroptosis of nucleus pulposus cells by promoting SLC7A11 translation. Aging Cell 2024; 23: e14210.","DOI":"10.1111\/acel.14210"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cytogfr.2025.06.007","article-title":"Ferroptosis in immune cells: implications for tumor immunity and cancer therapy","volume":"84","author":"Gao","year":"2025","unstructured":"Gao J, Zhang X, Liu Y and Gu X. Ferroptosis in immune cells: implications for tumor immunity and cancer therapy. Cytokine Growth Factor Rev 2025; 84: 59-73.","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41420-025-02415-x","article-title":"Ferroptosis: CD8(+)T cells’ blade to destroy tumor cells or poison for self-destruction","volume":"11","author":"Liang","year":"2025","unstructured":"Liang Y, Zhao Y, Qi Z, Li X and Zhao Y. Ferroptosis: CD8(+)T cells’ blade to destroy tumor cells or poison for self-destruction. Cell Death Discov 2025; 11: 128.","journal-title":"Cell Death Discov"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/8\/ajcr0167662.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:58:33Z","timestamp":1766023113000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/8\/ajcr0167662.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":95,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/kskh3925","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}